These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 22978683)
1. Molecular basis of drug resistance in A/H1N1 virus. Vergara-Jaque A; Poblete H; Lee EH; Schulten K; González-Nilo F; Chipot C J Chem Inf Model; 2012 Oct; 52(10):2650-6. PubMed ID: 22978683 [TBL] [Abstract][Full Text] [Related]
2. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase. Li L; Li Y; Zhang L; Hou T J Chem Inf Model; 2012 Oct; 52(10):2715-29. PubMed ID: 22998323 [TBL] [Abstract][Full Text] [Related]
3. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus. Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858 [TBL] [Abstract][Full Text] [Related]
4. Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations. Pan P; Li L; Li Y; Li D; Hou T Antiviral Res; 2013 Nov; 100(2):356-64. PubMed ID: 24055835 [TBL] [Abstract][Full Text] [Related]
5. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1. Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644 [TBL] [Abstract][Full Text] [Related]
6. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses. Singh A; Soliman ME Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512 [TBL] [Abstract][Full Text] [Related]
7. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir. Park JW; Jo WH J Chem Inf Model; 2009 Dec; 49(12):2735-41. PubMed ID: 19957991 [TBL] [Abstract][Full Text] [Related]
8. Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach. Karthick V; Shanthi V; Rajasekaran R; Ramanathan K Appl Biochem Biotechnol; 2012 May; 167(2):237-49. PubMed ID: 22544690 [TBL] [Abstract][Full Text] [Related]
9. In silico prediction of drug resistance due to S247R mutation of Influenza H1N1 neuraminidase protein. Mandal RS; Panda S; Das S J Biomol Struct Dyn; 2018 Mar; 36(4):966-980. PubMed ID: 28279127 [TBL] [Abstract][Full Text] [Related]
10. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442 [TBL] [Abstract][Full Text] [Related]
11. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase. Liu H; Yao X; Wang C; Han J Mol Pharm; 2010 Jun; 7(3):894-904. PubMed ID: 20420444 [TBL] [Abstract][Full Text] [Related]
12. In silico study on multidrug resistance conferred by I223R/H275Y double mutant neuraminidase. Tan H; Wei K; Bao J; Zhou X Mol Biosyst; 2013 Nov; 9(11):2764-74. PubMed ID: 24056678 [TBL] [Abstract][Full Text] [Related]
13. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections]. Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677 [TBL] [Abstract][Full Text] [Related]
14. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase. Kar P; Knecht V J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951 [TBL] [Abstract][Full Text] [Related]
15. Molecular prediction of oseltamivir efficiency against probable influenza A (H1N1-2009) mutants: molecular modeling approach. Rungrotmongkol T; Malaisree M; Nunthaboot N; Sompornpisut P; Hannongbua S Amino Acids; 2010 Jul; 39(2):393-8. PubMed ID: 20037767 [TBL] [Abstract][Full Text] [Related]
16. Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution. Rameix-Welti MA; Munier S; Le Gal S; Cuvelier F; Agou F; Enouf V; Naffakh N; van der Werf S Antivir Ther; 2011; 16(4):597-603. PubMed ID: 21685548 [TBL] [Abstract][Full Text] [Related]
17. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons. Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968 [TBL] [Abstract][Full Text] [Related]
18. Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach. Mai BK; Li MS Biochem Biophys Res Commun; 2011 Jul; 410(3):688-91. PubMed ID: 21693105 [TBL] [Abstract][Full Text] [Related]
19. Correlation analyses on binding affinity of sialic acid analogues and anti-influenza drugs with human neuraminidase using ab initio MO calculations on their complex structures--LERE-QSAR analysis (IV). Hitaoka S; Matoba H; Harada M; Yoshida T; Tsuji D; Hirokawa T; Itoh K; Chuman H J Chem Inf Model; 2011 Oct; 51(10):2706-16. PubMed ID: 21870866 [TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases. Le L; Lee EH; Hardy DJ; Truong TN; Schulten K PLoS Comput Biol; 2010 Sep; 6(9):. PubMed ID: 20885781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]